Elacridar Hydrochloride ron C(C1C=CC(CNCC2=CC=CC=N2)=CC=1)N1CCNCCCNCCNCCC1

C(C1C=CC(CNCC2=CC=CC=N2)=CC=1)N1CCNCCCNCCNCCC1

and improves lipid profile

LY2835219 free base (45 mg/kg

NAB2 was identified by an unbiased phenotypic screening

including the United Kingdom

Elacridar Hydrochloride ron C(C1C=CC(CNCC2=CC=CC=N2)=CC=1)N1CCNCCCNCCNCCC1Elacridar, also known as GF120918A, is a P glycoprotein (P gp) inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules. In vitro, GF120918A demonstrated high plasma protein binding across species, although a definitive protein binding evaluation was precluded by poor recovery, particularly in buffer and in mouse, rat, and dog